An Interactive Gaming-based Intervention for Back Pain

May 24, 2019 updated by: Paolo Bonato, Spaulding Rehabilitation Hospital

Augmenting Back Pain Exercise Therapy Using an Interactive Gaming-based Intervention in the Home Setting

This study aims to compare the outcomes of a traditional, exercise-based rehabilitation intervention for chronic low back pain with the outcomes achieved by combining a traditional intervention with adjunct therapy delivered using an interactive gaming-based system for home-based therapy.

Study Overview

Detailed Description

The study relies upon the Valedo system by Hocoma AG to implement an interactive gaming-based intervention (i.e. subjects receive part of their physical therapy by playing interactive video games). The system is similar to consumer electronics products for interactive gaming that track the subject's movements using body-worn sensors. The FDA has determined that the Valedo system is a 510(K) exempt device under the product code ION (i.e. exerciser, non-measuring device for Physical Medicine). In the study, subjects with non-specific chronic low back pain are randomized using a block design to one of two groups: group 1 receives usual care alone; group 2 receives an exercise-based rehabilitation intervention using interactive gaming in addition to usual care. Clinical assessments are performed at baseline and again 4 weeks and 8 weeks after baseline measures are gathered.

Study Type

Interventional

Enrollment (Actual)

7

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Massachusetts
      • Boston, Massachusetts, United States, 02129
        • Spaulding Rehabilitation Hospital Boston

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • English speaking
  • Back pain subject-rated > 3 on an 11 point visual-analog scale (0-10), with pain reported for a time > 6 months
  • Able to commit to all study visits
  • Low back pain attributable to mechanical etiology as opposed to infectious, neoplastic, or inflammatory causes.
  • BMI ≤ 40
  • Familiar with tablet use

Exclusion Criteria:

  • Vision or mobility impairment interfering with the performance of the interactive games
  • Current or anticipated receipt of payments from Worker's Compensation or other insurance for disability attributed to low back pain
  • Additional treatment for back pain during the period of the study, such as acupuncture
  • Unresolved musculoskeletal pathology of the lower limbs
  • Severe radiculopathic pain
  • Alcohol or substance abuse
  • Prior discectomy or implantation of rods, screws or plates (bulging disc without radicular pain is not exclusionary; hip or shoulder replacement is not exclusionary)
  • Current medication with coumadin or prednisone, chronic use of steroid medications, daily use of narcotic analgesics, or estrogen supplementation, tricyclic anti-depressants (if not on a regular steady dose at least one month prior to enrollment), or any substance that could impair balance.
  • Current diagnosis of:

    1. Balance problems due to vestibular or other neurological impairments.
    2. Osteoporosis (Osteopenia is not an exclusionary condition)
    3. Fibromyalgia
    4. Severe or progressive neurological deficits, including neuromotor impairment
    5. Any hypercoagulation condition
    6. Eczema, Psoriasis, or skin infections, and deep vein thrombosis
    7. Burns or other acute trauma including unhealed bone fractures or open wounds
    8. Psychiatric illness not well controlled, or current episode of exacerbated major depressive disorder
    9. Rheumatoid arthritis
  • Any other major medical condition that would impair the subject's ability to complete the study visits
  • Any other major medical condition that has not been stabilized, or that would impair the subject's ability to complete the activities required by the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Usual care
Subjects receive physical therapy for low back pain as typically prescribed in the clinic.
Subjects receive standard physical therapy, including outpatient visits as prescribed by the treating clinician and home-based exercises based on recommendations by the physical therapist.
Experimental: Interactive gaming
Subjects participate in an intervention combining usual care and home-based exercises using the Valedo system.
Subjects receive a combination of standard physical therapy in the clinic and home-based exercises that they perform using the Valedo system.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Analogue Pain Scale at 4 Weeks
Time Frame: Change from baseline in Visual Analogue Pain Scale score at 4 weeks
Subjects are asked to indicate their pain level using a visual analog scale, namely they are asked to choose the position on a horizontal line - drawn on a piece of paper - that corresponds to the pain level that they experience. The line is about 10 cm long and is divided into 10 intervals of equal length referred to as units. The minimum value on the scale is zero (meaning no pain). The maximum value on the scale is ten (meaning maximum ever experienced pain).
Change from baseline in Visual Analogue Pain Scale score at 4 weeks
Visual Analogue Pain Scale at 8 Weeks
Time Frame: Change from baseline in VAS score at 8 weeks
Subjects are asked to indicate their pain level using a visual analog scale, namely they are asked to choose the position on a horizontal line - drawn on a piece of paper - that corresponds to the pain level that they experience. The line is about 10 cm long and is divided into 10 intervals of equal length referred to as units. The minimum value on the scale is zero (meaning no pain). The maximum value on the scale is ten (meaning maximum ever experienced pain).
Change from baseline in VAS score at 8 weeks
Pain Frequency at 4 Weeks
Time Frame: Change in pain frequency at 4 weeks
Subjects are asked how many days they experienced low back pain during the week prior to the study visit.
Change in pain frequency at 4 weeks
Pain Frequency at 8 Weeks
Time Frame: Change in pain frequency at 8 weeks
Subjects are asked how many days they experienced low back pain during the week prior to the study visit.
Change in pain frequency at 8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Oswestry Low Back Pain Disability Questionnaire at 4 Weeks
Time Frame: Change in disability score at 4 weeks
Subjects are asked to fill in a questionnaire inquiring about how their pain interferes with their activities of daily living. Accordingly, they receive a disability score ranging between 0 and 100%. A score between 0 and 20% indicates minimal disability; a score between 21 and 40% indicates moderate disability; a score between 41 and 60% indicates severe disability; a score between 61 and 80% indicates that pain impinges on all aspects of the patient's life; and score between 81 and 100% indicates that the subject is bed-bound.
Change in disability score at 4 weeks
Oswestry Low Back Pain Disability Questionnaire at 8 Weeks
Time Frame: Change in disability score at 8 weeks
Subjects are asked to fill in a questionnaire inquiring about how their pain interferes with their activities of daily living. Accordingly, they receive a disability score ranging between 0 and 100%. A score between 0 and 20% indicates minimal disability; a score between 21 and 40% indicates moderate disability; a score between 41 and 60% indicates severe disability; a score between 61 and 80% indicates that pain impinges on all aspects of the patient's life; and score between 81 and 100% indicates that the subject is bed-bound.
Change in disability score at 8 weeks
SF36 at 4 Weeks
Time Frame: Change in clinical score at 4 weeks
The SF36 is a clinical outcome measure based on the administration of a questionnaire inquiring about the quality of life and health status of the subject. It consists of eight normalized (so that they have the some weight) scores related to vitality, physical functioning, bodily pain, general health perceptions, physical role functioning, emotional role functioning, social role functioning, and mental health. The lower the score the more disability. The higher the score the less disability. The score is provide as units on a scale from 0 to 100.
Change in clinical score at 4 weeks
SF36 at 8 Weeks
Time Frame: Change in clinical score at 8 weeks
The SF36 is a clinical outcome measure based on the administration of a questionnaire inquiring about the quality of life and health status of the subject. It consists of eight normalized (so that they have the some weight) scores related to vitality, physical functioning, bodily pain, general health perceptions, physical role functioning, emotional role functioning, social role functioning, and mental health. The lower the score the more disability. The higher the score the less disability. The score is provide as units on a scale from 0 to 100
Change in clinical score at 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2015

Primary Completion (Actual)

June 1, 2017

Study Completion (Actual)

June 1, 2017

Study Registration Dates

First Submitted

July 10, 2015

First Submitted That Met QC Criteria

July 17, 2015

First Posted (Estimate)

July 21, 2015

Study Record Updates

Last Update Posted (Actual)

May 28, 2019

Last Update Submitted That Met QC Criteria

May 24, 2019

Last Verified

May 1, 2019

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2015-P-000663

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Non-specific Chronic Low Back Pain

Clinical Trials on Usual care

Subscribe